JCR Pharmaceuticals Co Ltd JCRRF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 122.02M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 103.84
- Price/Sales
- 1.70
- Dividend Yield (Trailing)
- 3.36%
- Dividend Yield (Forward)
- 3.39%
- Dividend Payment Schedule
- Jun, Dec
- Total Yield
- 7.29%
Company Profile
JCR Pharmaceuticals Co Ltd is a drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth plan. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements. It operates in a single segment which is Pharmaceutical Business.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Core
- Total Number of Employees
- 985
- Website
- http://www.jcrpharm.co.jp
Valuation
|
Metric
|
JCRRF
|
|---|---|
Price/Earnings (Normalized) | 103.84 |
Price/Book Value | 1.71 |
Price/Sales | 1.70 |
Price/Cash Flow | 12.46 |
Price/Earnings
JCRRF
Financial Strength
|
Metric
|
JCRRF
|
|---|---|
Quick Ratio | 0.51 |
Current Ratio | 1.09 |
Interest Coverage | 4.81 |
Quick Ratio
JCRRF
Profitability
|
Metric
|
JCRRF
|
|---|---|
Return on Assets (Normalized) | −0.43% |
Return on Equity (Normalized) | −1.01% |
Return on Invested Capital (Normalized) | −0.20% |
Return on Assets
JCRRF
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| LOCK|x@bV^!C | LOCK|Tr$ | $1T | |||
| Johnson & Johnson
JNJ
| LOCK|>?JRN? | LOCK|mY& | $644B | |||
| AbbVie Inc
ABBV
| LOCK|RlZ#rK | LOCK|Gd% | $504B | |||
| Roche Holding AG ADR
RHHBY
| LOCK|!<x#Fkm | LOCK|gn^ | $380B | |||
| Merck & Co Inc
MRK
| LOCK|g^$%v> | LOCK|Q< | $363B | |||
| Novartis AG ADR
NVS
| LOCK|!F#Q<Hy^ | LOCK|Zy> | $297B | |||
| AstraZeneca PLC
AZN
| LOCK|y^S#XL> | LOCK|GY | $262B | |||
| Amgen Inc
AMGN
| LOCK|QHS??pdY | LOCK|X<Z | $242B | |||
| Gilead Sciences Inc
GILD
| LOCK|M&^<<l | LOCK|!^B | $195B | |||
| Novo Nordisk AS ADR
NVO
| LOCK|?cB%># | LOCK|^%K | $176B |
United States